Elron units plan TA stock sales

Elron Electronic Industries Ltd. said Sunday that three of its group companies have filed requests with the Israeli Securities Authority for a public offering of shares on the Tel Aviv Stock Exchange.

By JERUSALEM POST BUSINESS STAFF
April 30, 2007 07:26

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Elron Electronic Industries Ltd. said Sunday that three of its group companies have filed requests with the Israeli Securities Authority for a public offering of shares on the Tel Aviv Stock Exchange. BrainsGate Ltd., in which Elron holds approximately 22%, Starling Advanced Communications Ltd., in which Elron holds approximately 27% directly and approximately 46% indirectly through its 50.1% held subsidiary, RDC - Rafael Development Corporation, and SELA - Semiconductor Engineering Laboratories Ltd., in which it holds approximately 12% directly and approximately 54% indirectly through RDC, are all seeking to offer stock on the TASE and intend to list on the exchange during the second quarter of this year, or as soon as possible thereafter.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS